AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 142 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 6.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $256,852 | -9.2% | 16,733 | -3.5% | 0.21% | +29.0% |
| Q3 2022 | $283,000 | -21.6% | 17,334 | -30.3% | 0.16% | -25.7% |
| Q2 2022 | $361,000 | -63.2% | 24,864 | -53.2% | 0.22% | -65.1% |
| Q1 2022 | $982,000 | -6.7% | 53,164 | +20.0% | 0.62% | -25.5% |
| Q4 2021 | $1,053,000 | -24.8% | 44,294 | -22.1% | 0.84% | -9.5% |
| Q3 2021 | $1,400,000 | +102.0% | 56,852 | +78.8% | 0.93% | +79.8% |
| Q1 2021 | $693,000 | +1.9% | 31,797 | +19.2% | 0.52% | +18.7% |
| Q4 2020 | $680,000 | +40.5% | 26,665 | +55.0% | 0.43% | +22.9% |
| Q3 2020 | $484,000 | – | 17,202 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |